Academic Journal
View in EDS

From the bakery to the brain business: developing inducible yeast models of human neurodegenerative disorders

Bibliographic Details
Title: From the bakery to the brain business: developing inducible yeast models of human neurodegenerative disorders
Authors: Alejandro Ocampo, Antoni Barrientos
Source: BioTechniques, Vol 45, Iss 4S, Pp vii-xiv (2008)
Publisher Information: Taylor & Francis Group, 2008.
Publication Year: 2008
Collection: LCC:Biology (General)
Subject Terms: Biology (General), QH301-705.5
More Details: In the last decade, the budding yeast Saccharomyces cerevisiae has been used as a model system to study the mechanisms of the human aging process and of age-associated neurodegenerative disorders such as Parkinson's, Huntington's, Alzheimer's, and amyotrophic lateral sclerosis. S. cerevisiae is a facultative aerobic, unicellular yeast, and despite their simplicity, yeast cells possess most of the same basic cellular machinery as neurons in the brain, including pathways required for protein homeostasis and energy metabolism. The power of yeast genetics and the use of high-throughput screening technologies have provided important clues concerning the pathophysiology of these disorders and the identification of candidate therapeutic targets and drugs. The yeast models are based on the expression of human disease proteins in yeast and recapitulate some of the cytotoxic features observed in patients. However, the currently available models mostly suffer from high-level protein expression that results in acute cytotoxicity, and from metabolic constraints when the models are based on extensively used, strong, galactose-inducible promoters. The models would increase their significance if they were based on continuous and tightly regulated gene expression systems for both activation and levels of expression. This would allow for more chronic cytotoxicity that better simulates the timing of events that occur during disease progression. Additionally, the use of metabolism-independent inducers would allow for the study of cell toxicities under conditions where the cells are forced to exclusively respire, thus more reliably modeling the highly oxidative neuronal metabolism. Here we have constructed yeast models of Huntington's disease based on the expression, under the control of different promoters, of the first exon of the huntingtin-containing polyglutamine tracts of both wild-type and mutant lengths. The different models are compared and evaluated.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 00011274
1940-9818
0736-6205
Relation: https://doaj.org/toc/0736-6205; https://doaj.org/toc/1940-9818
DOI: 10.2144/000112746
Access URL: https://doaj.org/article/963ecbbd387b4b20949c4eff61a75ae2
Accession Number: edsdoj.963ecbbd387b4b20949c4eff61a75ae2
Database: Directory of Open Access Journals
FullText Text:
  Availability: 0
CustomLinks:
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edsdoj&genre=article&issn=00011274&ISBN=&volume=45&issue=4S&date=20081001&spage=&pages=&title=BioTechniques&atitle=From%20the%20bakery%20to%20the%20brain%20business%3A%20developing%20inducible%20yeast%20models%20of%20human%20neurodegenerative%20disorders&aulast=Alejandro%20Ocampo&id=DOI:10.2144/000112746
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
  – Url: https://doaj.org/article/963ecbbd387b4b20949c4eff61a75ae2
    Name: EDS - DOAJ (s8985755)
    Category: fullText
    Text: View record from DOAJ
    MouseOverText: View record from DOAJ
Header DbId: edsdoj
DbLabel: Directory of Open Access Journals
An: edsdoj.963ecbbd387b4b20949c4eff61a75ae2
RelevancyScore: 839
AccessLevel: 3
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 838.784057617188
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: From the bakery to the brain business: developing inducible yeast models of human neurodegenerative disorders
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Alejandro+Ocampo%22">Alejandro Ocampo</searchLink><br /><searchLink fieldCode="AR" term="%22Antoni+Barrientos%22">Antoni Barrientos</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: BioTechniques, Vol 45, Iss 4S, Pp vii-xiv (2008)
– Name: Publisher
  Label: Publisher Information
  Group: PubInfo
  Data: Taylor & Francis Group, 2008.
– Name: DatePubCY
  Label: Publication Year
  Group: Date
  Data: 2008
– Name: Subset
  Label: Collection
  Group: HoldingsInfo
  Data: LCC:Biology (General)
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Biology+%28General%29%22">Biology (General)</searchLink><br /><searchLink fieldCode="DE" term="%22QH301-705%2E5%22">QH301-705.5</searchLink>
– Name: Abstract
  Label: Description
  Group: Ab
  Data: In the last decade, the budding yeast Saccharomyces cerevisiae has been used as a model system to study the mechanisms of the human aging process and of age-associated neurodegenerative disorders such as Parkinson's, Huntington's, Alzheimer's, and amyotrophic lateral sclerosis. S. cerevisiae is a facultative aerobic, unicellular yeast, and despite their simplicity, yeast cells possess most of the same basic cellular machinery as neurons in the brain, including pathways required for protein homeostasis and energy metabolism. The power of yeast genetics and the use of high-throughput screening technologies have provided important clues concerning the pathophysiology of these disorders and the identification of candidate therapeutic targets and drugs. The yeast models are based on the expression of human disease proteins in yeast and recapitulate some of the cytotoxic features observed in patients. However, the currently available models mostly suffer from high-level protein expression that results in acute cytotoxicity, and from metabolic constraints when the models are based on extensively used, strong, galactose-inducible promoters. The models would increase their significance if they were based on continuous and tightly regulated gene expression systems for both activation and levels of expression. This would allow for more chronic cytotoxicity that better simulates the timing of events that occur during disease progression. Additionally, the use of metabolism-independent inducers would allow for the study of cell toxicities under conditions where the cells are forced to exclusively respire, thus more reliably modeling the highly oxidative neuronal metabolism. Here we have constructed yeast models of Huntington's disease based on the expression, under the control of different promoters, of the first exon of the huntingtin-containing polyglutamine tracts of both wild-type and mutant lengths. The different models are compared and evaluated.
– Name: TypeDocument
  Label: Document Type
  Group: TypDoc
  Data: article
– Name: Format
  Label: File Description
  Group: SrcInfo
  Data: electronic resource
– Name: Language
  Label: Language
  Group: Lang
  Data: English
– Name: ISSN
  Label: ISSN
  Group: ISSN
  Data: 00011274<br />1940-9818<br />0736-6205
– Name: NoteTitleSource
  Label: Relation
  Group: SrcInfo
  Data: https://doaj.org/toc/0736-6205; https://doaj.org/toc/1940-9818
– Name: DOI
  Label: DOI
  Group: ID
  Data: 10.2144/000112746
– Name: URL
  Label: Access URL
  Group: URL
  Data: <link linkTarget="URL" linkTerm="https://doaj.org/article/963ecbbd387b4b20949c4eff61a75ae2" linkWindow="_blank">https://doaj.org/article/963ecbbd387b4b20949c4eff61a75ae2</link>
– Name: AN
  Label: Accession Number
  Group: ID
  Data: edsdoj.963ecbbd387b4b20949c4eff61a75ae2
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.963ecbbd387b4b20949c4eff61a75ae2
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2144/000112746
    Languages:
      – Text: English
    Subjects:
      – SubjectFull: Biology (General)
        Type: general
      – SubjectFull: QH301-705.5
        Type: general
    Titles:
      – TitleFull: From the bakery to the brain business: developing inducible yeast models of human neurodegenerative disorders
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Alejandro Ocampo
      – PersonEntity:
          Name:
            NameFull: Antoni Barrientos
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Type: published
              Y: 2008
          Identifiers:
            – Type: issn-print
              Value: 00011274
            – Type: issn-print
              Value: 19409818
            – Type: issn-print
              Value: 07366205
          Numbering:
            – Type: volume
              Value: 45
            – Type: issue
              Value: 4S
          Titles:
            – TitleFull: BioTechniques
              Type: main
ResultId 1